MCL1 and pancreatic neoplasm: Overexpression of miR-204, either by a miR-204 mimic or by triptolide treatment, downregulates myeloid cell leukemia-1 (Mcl-1) by directly binding to the Mcl-1 3′ UTR and causes a subsequent decrease in cell viability and pancreatic cancer cell death [103].